02.10.2015 Views

studies

2015SupplementFULLTEXT

2015SupplementFULLTEXT

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

1242A AASLD ABSTRACTS HEPATOLOGY, October, 2015<br />

2123<br />

Liver Plasmacytoid Dendritic Cells Expressing miR-181<br />

prolong graft survival by increasing T Regulatory cells<br />

and Decreasing B cells as Revealed by Mass Cytometry<br />

(CyTOF<br />

Audrey H. Lau 1 , Matthew J. Vitalone 2 , Xiumei Qu 2 , Todd Shawler 2 ,<br />

Olivia M. Martinez 2 , Carlos O. Esquivel 2 , Sheri M. Krams 2 ; 1 Pediatrics,<br />

Division of Gastroenterology, Hepatology, and Nutrition,<br />

Stanford/LPCH, San Francisco, CA; 2 Surgery, Stanford University,<br />

Stanford, CA<br />

Liver allografts are well tolerated and other solid organ<br />

allografts, when transplanted concurrently with livers, show<br />

improved outcomes. However, the mechanisms underlying<br />

“hepatic tolerance” have yet to be elucidated. Previous data<br />

show that hepatic dendritic cells (DC) have diminished antigen<br />

presentation and immune stimulatory function compared<br />

with DC in lymphoid tissue. Immature plasmacytoid (p)DC have<br />

been shown to induce graft prolongation and we have previously<br />

shown miR-181a1b1 is increased in pDC as compared<br />

to conventional DC. Wild-type (WT) BALB/c mice were transplanted<br />

with allogeneic (C57BL/6) vascularized heterotopic<br />

heart grafts. Animals received either no treatment (n=3) or were<br />

injected i.v. with 0.5×10 6 hepatic pDC (n=5) or miR-181a1b1 -/-<br />

(KO) pDC (n=3) at day (D)−7 from transplant. Recipients with<br />

no treatment rejected their allograft by D7 while recipients pretreated<br />

with hepatic pDC had significantly prolonged allograft<br />

survival to D15-21 (p1.5<br />

yrs) Opn -/- mice, which displayed significant hepatomegaly<br />

and splenomegaly compared to their age-matched WT littermates.<br />

Morphological features consisted of small aggregates<br />

of cells with intensely basophilic nuclei and clusters of immature<br />

and mature myeloid cells located in the sinusoids and in<br />

the portal areas. Accumulation of HSCs occurred also in the<br />

spleen but to a much lesser extent in the kidney and in the lung.<br />

Furthermore, Opn -/- mice showed premature exit of immature<br />

hematopoietic cells from the bone marrow to the spleen and<br />

to the liver, increased cellularity of lineage-negative cells and<br />

elevated hepatic GCSF, CXCL1, MCSF, MIP1α, RANTES and<br />

TNFα as well as serum MCSF and CXCL1 compared to WT<br />

littermates. Opn -/- mice also presented numerous iron deposits<br />

in the periportal zone of the liver, in the bone marrow and in<br />

the spleen but they were minimal in the lung and were absent<br />

in the heart and in the kidney, suggesting dysregulation of iron<br />

metabolism in the absence of Opn compared to WT littermates.<br />

CONCLUSION: These results suggest a critical role for OPN in<br />

HSC homeostasis by regulation of bone marrow homing and<br />

modulation of cytokine levels involved in their development.<br />

Disclosures:<br />

The following authors have nothing to disclose: Fernando Magdaleno, Xiadong<br />

Ge, Holger Fey, Costica Aloman, M. Isabel Fiel, Natalia Nieto<br />

2125<br />

IL-17A plays a pivotal role in LPS/GalN-induced fulminant<br />

hepatic injury in mice.<br />

Hiroshi Kono, Shinji Furuya, Chao Sun, Hideki Fujii; First Department<br />

of Surgry, University of Yamanashi, Chuo, Japan<br />

Background Lipopolysaccharide/D-Galactosamine (LPS/Gal-<br />

N)-induced hepatic injury is an experimental model of fulminant<br />

hepatic failure in which tumor necrosis factor-a (TNF-a) plays<br />

a pivotal role. Moreover, it was reported from our laboratory<br />

that interleukin (IL)-17A enhanced production of TNF-a by the<br />

Kupffer cell. Objective The purpose of this study was to determine<br />

the role of IL-17A in LPS/GalN-induced hepatic injury<br />

in mice. Methods LPS/GalN was injected into three mouse<br />

models: wild-type (WT) mice, IL-17A knockout (KO) mice, or<br />

IL-17A knockout mice treated with recombinant mouse (rm)<br />

IL-17A homodimer (KO + rmIL-17A). Survival was assessed<br />

for 24 hours after LPS/GalN injection, and histopathologic<br />

findings were evaluated at various time points after LPS/GalN<br />

injection for neutrophil and apoptosis markers. After LPS/GalN<br />

injection, expression of the inflammatory mediators TNF-a, IL-6,<br />

monocyte chemotactic protein (MCP)-1, IL-17A, high mobil-

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!